Results 11 to 20 of about 1,126,566 (371)

Comparative clinical efficacy and safety of the proposed biosimilar ABP 710 with infliximab reference product in patients with rheumatoid arthritis

open access: yesArthritis Research & Therapy, 2020
Background ABP 710 is being developed as a biosimilar to infliximab reference product (RP). Analytical similarity and pharmacokinetic equivalence between the two have been previously demonstrated.
Mark C. Genovese   +9 more
doaj   +2 more sources

Equine dermatopathies in southern Brazil: a study of 710 cases

open access: yesCiência Rural, 2015
A retrospective study of equine skin diseases diagnosed in the Laboratório Regional de Diagnóstico, Faculdade de Veterinária, Universidade Federal de Pelotas was conducted between 1978 and 2013.
Nathalia Dode de Assis-Brasil   +8 more
doaj   +2 more sources

Long-Term Multiwavelength Studies of High-Redshift Blazar 0836+710 [PDF]

open access: yes, 2013
Aims. The observation of gamma -ray flares from blazar 0836+710 in 2011, following a period of quiescence, offered an opportunity to study correlated activity at different wavelengths for a high-redshift (z=2.218) active galactic nucleus.
Akyuz, A.   +9 more
core   +2 more sources

S5 0836+710: An FRII jet disrupted by the growth of a helical instability? [PDF]

open access: yes, 2012
The remarkable stability of extragalactic jets is surprising, given the reasonable possibility of the growth of instabilities. In addition, much work in the literature has invoked this possibility in order to explain observed jet structures and obtain ...
Hardee, Philip E.   +3 more
core   +2 more sources

A Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab Biosimilar

open access: yesAdvances in Therapy, 2021
ABP 710 (AVSOLA ® ) is a biosimilar to infliximab reference product (RP), a monoclonal antibody targeting tumor necrosis factor alpha (TNFα). It is approved in the USA and Canada for all the same indications as infliximab RP.
W. Reinisch   +7 more
semanticscholar   +1 more source

Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product

open access: yesPharmaceutical Research, 2020
Purpose ABP 710 has been developed as a biosimilar to infliximab reference product (RP). The objective of this study was to assess analytical similarity (structural and functional) between ABP 710 and infliximab RP licensed by the United States Food and ...
Ramsey Saleem   +6 more
semanticscholar   +1 more source

Multiband RadioAstron space VLBI imaging of the jet in quasar S5 0836+710 [PDF]

open access: yesAstronomy & Astrophysics, 2019
Context. Detailed studies of relativistic jets in active galactic nuclei (AGN) require high-fidelity imaging at the highest possible resolution. This can be achieved using very long baseline interferometry (VLBI) at radio frequencies, combining worldwide
L. Vega-Garc'ia   +14 more
semanticscholar   +1 more source

Carrier scattering approach to the origins of dark current in mid- and far-infrared (terahertz) quantum-well intersubband photodetectors (QWIPs) [PDF]

open access: yes, 2001
A carrier scattering approach is taken in an analysis of the affect on the dark current of extending the operating wavelength of conventional bound to continuum quantum-well intersubband photodetectors. It is found that both the sequential tunneling and
Etteh, N.E.I., Harrison, P.
core   +1 more source

NuSTAR AND MULTIFREQUENCY STUDY OF THE TWO HIGH-REDSHIFT BLAZARS S5 0836+710 AND PKS 2149–306 [PDF]

open access: yes, 2015
Powerful blazars are flat-spectrum radio quasars whose emission is dominated by a Compton component peaking between a few hundred keV and a few hundred MeV.
G. Tagliaferri   +31 more
semanticscholar   +1 more source

Chronic Hepatitis B Infection Is Associated with Increased Molecular Degree of Inflammatory Perturbation in Peripheral Blood

open access: yesViruses, 2020
Hepatitis B virus (HBV) infection remains a major public health concern. The interaction between HBV and the host inflammatory response is an important contributing factor driving liver damage and diseases outcomes.
Caian L. Vinhaes   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy